Search research articles
Contact Us
Filters
Showing results (601-610 of 711) with videos related to
Page
of 72
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 1998
A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide
L A Hammond, J R Eckardt, R Ganapathi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2001
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
M Hidalgo, L L Siu, J Nemunaitis, et al.
Abdominal Imaging
|
August 17, 2014
Fluoroscopic findings post-peroral esophageal myotomy
Carla Harmath, Jeanne Horowitz, Senta Berggruen, et al.
Oncoimmunology
|
November 21, 2015
A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4<sup>+</sup> T cell receptor repertoire clonality
Wei Zhu, Claire Germain, Zheng Liu, et al.
Blood
|
December 10, 2020
MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulus
Elizabeth Bulaeva, Davide Pellacani, Naoto Nakamichi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2004
Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity
J S de Bono, S Y Rha, J Stephenson, et al.
Cancer Immunology Research
|
August 30, 2017
Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis
Rajeev K Shrimali, Shamim Ahmad, Vivek Verma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2000
DX-8951f, a hexacyclic camptothecin analog, on a daily-times-five schedule: a phase I and pharmacokinetic study in patients with advanced solid malignancies
E K Rowinsky, T R Johnson, C E Geyer, et al.
BMC Public Health
|
March 21, 2023
Community coalition efforts to prevent childhood obesity: two-year results of the Shape Up Under 5 study
Christina D Economos, Larissa Calancie, Ariella R Korn, et al.
Immunogenetics
|
June 6, 2018
Nomenclature for the KIR of non-human species
James Robinson, Lisbeth A Guethlein, Giuseppe Maccari, et al.
Page
of 72
Search research articles
Search
Showing results (601-610 of 711) with videos related to
Sort By:
Page
of 72
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 1998
A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide
L A Hammond, J R Eckardt, R Ganapathi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2001
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
M Hidalgo, L L Siu, J Nemunaitis, et al.
Abdominal Imaging
|
August 17, 2014
Fluoroscopic findings post-peroral esophageal myotomy
Carla Harmath, Jeanne Horowitz, Senta Berggruen, et al.
Oncoimmunology
|
November 21, 2015
A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4<sup>+</sup> T cell receptor repertoire clonality
Wei Zhu, Claire Germain, Zheng Liu, et al.
Blood
|
December 10, 2020
MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulus
Elizabeth Bulaeva, Davide Pellacani, Naoto Nakamichi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2004
Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity
J S de Bono, S Y Rha, J Stephenson, et al.
Cancer Immunology Research
|
August 30, 2017
Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis
Rajeev K Shrimali, Shamim Ahmad, Vivek Verma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2000
DX-8951f, a hexacyclic camptothecin analog, on a daily-times-five schedule: a phase I and pharmacokinetic study in patients with advanced solid malignancies
E K Rowinsky, T R Johnson, C E Geyer, et al.
BMC Public Health
|
March 21, 2023
Community coalition efforts to prevent childhood obesity: two-year results of the Shape Up Under 5 study
Christina D Economos, Larissa Calancie, Ariella R Korn, et al.
Immunogenetics
|
June 6, 2018
Nomenclature for the KIR of non-human species
James Robinson, Lisbeth A Guethlein, Giuseppe Maccari, et al.
Page
of 72